newsfilter
← Latest News
GlobeNewswire·

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome

CAMBRIDGE, Mass. and DALLAS and TAMPA, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc., (NASDAQ:TSHA) (Taysha), a clinical-stage biotechnology company focused on developing adeno-associated virus